여성용 의료기기 시장, 시장 기회, 성장 촉진요인, 산업 동향 분석과 예측(2024-2032년)

The Global Women Health Devices Market was valued at approximately USD 129.9 billion in 2023 and is projected to grow at a CAGR of 9.2% from 2024 to 2032. Women's health devices include medical instruments, equipment, and tools designed for diagnosing, monitoring, and treating health conditions unique to women. These devices address the anatomical and physiological needs of women throughout various life stages, from adolescence to menopause and beyond. They cover reproductive health, gynecological care, and conditions like breast cancer, cervical cancer, osteoporosis, and pelvic floor disorders. The aging global population, particularly among women, is increasing urinary incontinence issues. This condition, often due to weakened pelvic floor muscles, affects about 25 million adults in the U.S., with 75-80% being women, and around 200 million worldwide.

The overall women health devices industry is classified based on the product, application, end use r, and region.

The women health devices market is divided into devices and consumables. The devices segment includes contraceptive devices, fertility monitoring tools, menstrual health products, breast and pelvic health devices, maternal health products, general health monitors, gynecological medical devices, and more. Forecasts suggest this segment will reach USD 211.4 billion by 2032. Several factors drive this growth: heightened awareness among women about their health needs, the emergence of specialized devices, technological advancements yielding efficient and user-friendly products, and a societal shift towards preventive healthcare.

The market is divided into areas like cancer, osteoporosis, infectious diseases, uterine fibroids, pregnancy, female sterilization, and menstrual disorders. The infectious diseases segment is set to grow at a CAGR of 7.9% during the analysis period. Infectious diseases affecting women, such as urinary tract infections (UTIs), sexually transmitted infections (STIs), and vaginal infections, are globally prevalent. For instance, the WHO reported in 2022 that twenty million women were HIV-positive, with 540,000 new cases and 23,000 related deaths.

In the U.S., the women health devices market is projected to reach USD 78.8 billion by 2032. Heightened awareness about women's health and preventive care drives the demand for specialized devices. Initiatives promoting regular screenings and early diagnoses, especially for breast cancer and osteoporosis, further fuel this growth. Other growth drivers include rising healthcare expenditures, supportive government initiatives, medical technology advancements, and the increasing prevalence of lifestyle-related diseases. Together, these factors enhance women's healthcare accessibility and quality, expanding the market.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry impact forces
  • 3.1.1 Growth drivers
    • 3.1.1.1 Increasing disease burden among women in developed countries
    • 3.1.1.2 Rising elderly female population worldwide
    • 3.1.1.3 Technological advancements in healthcare industry
    • 3.1.1.4 Increasing awareness regarding women health in developing countries
  • 3.1.2 Industry pitfalls and challenges
    • 3.1.2.1 High cost of devices and procedures
    • 3.1.2.2 Lack of awareness among women in underdeveloped economies
• 3.2 Growth potential analysis
• 3.3 Technology landscape
• 3.4 Future market trends
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Devices
  • 5.2.1 Contraceptive devices
  • 5.2.2 Fertility monitoring devices
  • 5.2.3 Menstrual health products
  • 5.2.4 Breast health devices
  • 5.2.5 Pelvic health devices
  • 5.2.6 Maternal health products
  • 5.2.7 General health monitoring devices
  • 5.2.8 Medical devices for gynecological conditions
  • 5.2.9 Other devices
• 5.3 Consumables

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Cancer
• 6.3 Osteoporosis
• 6.4 Infectious diseases
• 6.5 Uterine fibroids
• 6.6 Pregnancy
• 6.7 Female sterilization
• 6.8 Menstrual disorders
• 6.9 Other applications

Chapter 7 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Obstetrics and gynecology clinics
• 7.4 Diagnostic laboratories
• 7.5 Ambulatory surgical centers
• 7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Russia
  • 8.3.7 Denmark
  • 8.3.8 Sweden
  • 8.3.9 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Qatar
  • 8.6.5 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 Allengers Medical
• 9.3 Alphabet Inc.
• 9.4 Caldera Medical
• 9.5 Carestream Health
• 9.6 Garmin Ltd.
• 9.7 GE Healthcare Technologies Inc.
• 9.8 Hologic, Inc.
• 9.9 Koninklijke Philips N.V.
• 9.10 Mankind Pharma Limited
• 9.11 OMRON Corporation
• 9.12 Organon and Co.
• 9.13 Samsung Electronics co., Ltd.
• 9.14 The Cooper Companies, Inc.